Brand name: Diarrhoea Relief (Pharmacy Action) TM
Active ingredients: loperamide
What it is used for
Symptomatic treatment of acute non-specific diarrhoea. Control and symptomatic treatment of chronic diarrhoea.
How to take it
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
- The way to take this medicine: Oral
- Store below 25 degrees Celsius
- Lifetime is 3 Years.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
Hard gelatin capsule with grey cap and green body
Images are the copyright of the Pharmacy Guild of Australia
Do I need a prescription?
This medicine is available from a pharmacy without prescription.It is
Pregnant or planning a pregnancy?
For the active ingredient loperamide
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Need more information?
These trusted information partners have more on this topic.
Top results
Cholera - myDr.com.au
Cholera is a diarrhoeal illness caused by infection of the bowel with the bacterium Vibrio cholerae. Many people have only mild symptoms. A vaccine is available.
Read more on myDr website
Maxor Heartburn Relief Capsules - myDr.com.au
Maxor Heartburn Relief Capsules - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Salpraz Heartburn Relief Tablets - myDr.com.au
Salpraz Heartburn Relief Tablets - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Suvacid Heartburn Relief Tablets - myDr.com.au
Suvacid Heartburn Relief Tablets - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
APOHealth Cold Relief Tablets - myDr.com.au
APOHealth Cold Relief Tablets - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Sudafed Sinus + Pain Relief Tablets - myDr.com.au
Sudafed Sinus + Pain Relief Tablets - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Sensease Nasal Allergy Relief Nasal Spray - myDr.com.au
Sensease Nasal Allergy Relief Nasal Spray - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
APO-Pantoprazole Heartburn Relief Tablets - myDr.com.au
APO-Pantoprazole Heartburn Relief Tablets - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
APO-Prochlorperazine Nausea Relief Tablets - myDr.com.au
APO-Prochlorperazine Nausea Relief Tablets - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Sudafed Sinus + Anti-inflammatory Pain Relief Caplets - myDr.com.au
Sudafed Sinus + Anti-inflammatory Pain Relief Caplets - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Top results
Celiac plexus block (CPB) in patients with unresectable pancreatic cancer-related pain | Cochrane
Abdominal pain is a major symptom in patients with inoperable pancreatic cancer and is often difficult to treat. Celiac plexus block (CPB) is a safe and effective method for reducing this pain. It involves the chemical destruction of the nerve fibres that convey pain from the abdomen to the brain. We searched for studies comparing CPB with standard analgesic therapy in patients with inoperable pancreatic cancer. We were interested in the primary outcome of pain, measured on a visual analogue scale (VAS). We also looked at the amount of opioid (morphine-like drugs) patients took (opioid consumption) and adverse effects of the treatment. Six studies (358 participants) comparing CPB with standard therapy (painkillers) met our inclusion criteria.At four weeks pain scores were significantly lower in the CPB group. Opioid consumption was also significantly lower than in the control group.The main adverse effects were diarrhoea or constipation (this symptom was significantly more likely in the control group, where opioid consumption was higher). Endoscopic ultrasonography (EUS)-guided CPB is becoming popular as a minimally invasive technique that has fewer risks, but we were not able to find any RCTs assessing this method (current medical literature on this subject is limited to studies without control groups). Although the data on EUS-guided CPB and pain control are promising, we await rigorously designed RCTs that may validate these findings. We conclude that, although statistical evidence is minimal for the superiority of pain relief over analgesic therapy, the fact that CPB causes fewer adverse effects than opioids is important for patients.
Read more on Cochrane (Australasian Centre) website
Title: Chinese herbal medicines for menopausal symptoms | Cochrane
Background: Menopause usually takes place when a woman is around 51 years of age. Women can experience symptoms such as hot flushes, sweats, poor sleep, joint pains, anxiousness, dry skin and vagina when the organs which produce female hormones slow down. Usually hormone therapy (HT) is prescribed to reduce the symptoms.
Read more on Cochrane (Australasian Centre) website
Janus kinase inhibitors in myeloproliferative neoplasms: Clinical applications | Issue 5 | Volume 37 | Australian Prescriber
Hyperactive Janus kinase 2 signalling is a key molecular event in polycythaemia, essential thrombocythaemia and myelofibrosis. This is associated with the...
Read more on Australian Prescriber website
Treatment for Alzheimers disease: has anything changed? | Issue 2 | Volume 38 | Australian Prescriber
Current therapies for Alzheimers disease do not modify the course of disease and are not universally beneficial. Clinical trials of drugs targeting amyloid...
Read more on Australian Prescriber website
The management of gastro-oesophageal reflux disease | Issue 1 | Volume 39 | Australian Prescriber
If there are no features of serious disease, suspected gastro-oesophageal reflux disease can be.
Read more on Australian Prescriber website
Panic | CRUfAD
CONTACT US URGENT CARE About Us Our Research For Patients For Clinicians Select Page Panic Management plan for Panic Disorder Pages 246-257 from the Management of Mental Disorders, published by World Health Organization, Sydney
Read more on CRUfAD – Clinical Research Unit for Anxiety and Depression website
Agoraphobia | CRUfAD
CONTACT US URGENT CARE About Us Our Research For Patients For Clinicians Select Page Agoraphobia Panic disorder and Agoraphobia Pages 246-257 from the Management of Mental Disorders, published by World Health Organization, Sydney
Read more on CRUfAD – Clinical Research Unit for Anxiety and Depression website
